Levothyroxine in Pregnancy Did Not Affect Neonatal Admission Rates
Women being treated with levothyroxine were administered a daily morning dose throughout pregnancy starting 4-8 days after her first prenatal visit.
Investigators reported outcomes of a randomized phase 3 trial that assessed the use of radioactive iodine following surgical resection in patients with low-risk thyroid cancer.
Investigators sought to assess the link between treatment for thyroid cancer and subsequent cardiac and vascular complications.
On laboratory tests, the authors identified an unusual endocrine hormonal profile, including pituitary hormones below reference intervals and gonadal and adrenal hormones above reference intervals.